Both in Pharmaceuticals
Pasithea Therapeutics vs Actuate Therapeutics
Over the past year KTTA returned −31.9% and ACTU returned −89.9%; their daily moves had a correlation of 0.14.
KTTA −31.9% ACTU −89.9%Growth of $1, one year, split-adjusted
| Metric | KTTA | ACTU |
|---|---|---|
| Price | $0.4900 | $0.6860 |
| Market cap | $16.4M | $16.5M |
| Today | +2.08% | −6.82% |
| 1 month | −12.5% | −58.5% |
| 6 months | −31.5% | −70.0% |
| Year to date | −62.0% | −88.8% |
| 1 year | −32.6% | −90.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $45.7M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 63.3% | 134.6% |
| Short % of float | 0.8% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).